1,749
Views
14
CrossRef citations to date
0
Altmetric
Article; Medical Biotechnology

Whole genome microarray analysis in non-small cell lung cancer

, , , , , , , & show all
Pages 111-118 | Received 24 Oct 2014, Accepted 10 Nov 2014, Published online: 19 Jan 2015

References

  • Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J. 2001;18(6):1059–1068.
  • American Cancer Society [Internet]. American Cancer Society, Inc.; c2014 [cited 2014 Oct 10]. Available from: http://www.cancer.org/cancer/lungcancer-non-smallcell/.
  • Liu K, Zhan M, Zheng P. Loss of p73 expression in six non-small cell lung cancer cell lines is associated with 5’CpG island methylation. Exp Mol Pathol. 2008;84(1):59–63.
  • Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83(5):584–594.
  • Leelakumari S, Madhavan J, Ankathil R. A multigenic approach to predict risk and survival among Indian lung cancer patients: P1-042. J Thorac Oncol. 2007;2(8):S566.
  • Cherneva R, Dimova I. Genetic aspects of lung cancer. Balkan J Med Genet. 2006;9(1–2):9–17.
  • Al Zeyadi MM. Molecular and genetic aspects of lung cancer. Biotechnol Biotechnol Equipment. 2013;27(5):4051–4060.
  • Herbst RS, Heymach JV, Lippman SM. Molecular origins of cancer: lung cancer. New England J Med. 2008;359:1367–1380.
  • Haigentz M, Perez-Soler R. Chemopreventive therapeutics inhalation therapies for lung cancer and bronchial premalignancy. Methods Mol Med. 2003;75:771–780.
  • International Union Against Cancer [Internet]. TNM classification of malignant tumours. UICC; c2014 [cited 2014 Oct 10]. Available from: http://www.uicc.org/resources/tnm.
  • Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo WL, Gray JW, Pinkel D. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet. 2000;25(2):144–146.
  • Dehan E, Ben-Dor A, Liao W, Lipson D, Frimer H, Rienstein S, Simansky D, Krupsky M, Yaron P, Friedman E, Rechavi G, Perlman M, Aviram-Goldring A, Izraeli S, Bittner M, Yakhini Z, Kaminski N. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer. 2007;56(2):175–184.
  • Brena RM. Aberrant DNA methylation in human non-small cell lung cancer [ dissertation]. Columbus (OH): The Ohio State University; 2007. Available from: https://etd.ohiolink.edu/.
  • Boelens MC, Kok K, van der Vlies P, van der Vries G, Sietsma H, Timens W, Postma DS, Groen HJ, van den Berg A. Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis. Lung Cancer. 2009;66(3):372–378.
  • Baik SH, Jee BK, Choi JS, Yoon HK, Lee KH, Kim YH, Lim Y. DNA profiling by array comparative genomic hybridization (CGH) of peripheral blood mononuclear cells (PBMC) and tumor tissue cell in non-small cell lung cancer (NSCLC). Mol Biol Rep. 2009;36(7):1767–1778.
  • Sung JS, Park KH, Kim YH. Genomic alterations of chromosome region 11p as predictive marker by array comparative genomic hybridization in lung adenocarcinoma patients. Cancer Genet Cytogenet. 2010;198(1):27–34.
  • Wistuba II, Behrens C, Virmani AK, Mele G, Milchgrub S, Girard L, Fondon JW 3rd, Garner HR, McKay B, Latif F, Lerman MI, Lam S, Gazdar AF, Minna JD. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 2000;60(7):1949–1960.
  • Nomoto S, Haruki N, Tatematsu Y, Konishi H, Mitsudomi T, Takahashi T, Takahashi T. Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers. Genes Chromosomes Cancer. 2000;28(3):342–346.